| Literature DB >> 34593853 |
Neeraj Kumar1, Dilip Kumar Singh2, Shashi Bhushan2, Ankur Jamwal3.
Abstract
Effects of a novel dietary mixture of selenium nanoparticles (Se-NPs) and omega-3-fatty acids i.e., Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on mitigating arsenic pollution, high-temperature stress and bacterial infection were investigated in Pangasianodon hypophthalmus. To aim this, four isocaloric and iso-nitrogenous diets were prepared: control feed (no supplementation), Se-NPs at 0.2 mg kg-1 diet with EPA + DHA at 0.2, 0.4 and 0.6% as supplemented diets. Fish were reared under normal condition or concurrent exposure to arsenic (2.65 mg L-1), and temperature (34 °C) (As + T) stress for 105 days. The experiment was conducted with eight treatments in triplicates. Response to various stresses i.e., primary (cortisol), secondary (oxidative stress, immunity, and stress biomarkers) and tertiary stress response (growth performance, bioaccumulation and mortality due to bacterial infection) were determined. Supplementation of dietary Se-NPs at 0.2 mg kg-1 diet and EPA + DHA at 0.2 and 0.4% reduced the primary stress level. Exposure to arsenic and temperature (As + T) and fed with control diet and EPA + DHA at 0.6% aggravated the cortisol level. Anti-oxidative enzymes (Catalase, superoxide dismutase, glutathione peroxidase and glutathione-s-transferase) and immunity (Nitroblue tetrazolium, total protein, albumin, globulin, A:G ratio, total immunoglobulin and myeloperoxidase) of the fish were augmented by supplementation of Se-NPs and EPA + DHA at 0.2 and 0.4%. Neurotransmitter enzyme, HSP 70, Vitamin C were significantly enhanced (p < 0.01) with supplementation of Se-NPs at 0.2 mg kg-1 and EPA + DHA at 0.2 and 0.4%. Whereas total lipid, cholesterol, phospholipid, triglyceride and very low-density lipoprotein (VLDL) were reduced (p < 0.01) with the supplementation of Se-NPs at 0.2 mg kg-1 diet and EPA + DHA at 0.2 and 0.4%. Tertiary stress response viz. growth performance was also significantly enhanced with supplementation of Se-NPs at 0.2 mg kg-1 and EPA + DHA at 0.2 and 0.4% reared under As + T. Whereas arsenic bioaccumulation in fish tissues was significantly reduced with dietary supplementation of Se-NPs and EPA + DHA. Cumulative mortality and relative percentage survival were reduced with Se-NPs at 0.2 mg kg-1 and EPA + DHA at 0.2 and 0.4%. The investigation revealed that a novel combination of Se-NPs at 0.2 mg kg-1 and EPA + DHA at 0.4% followed by 0.2% has the potential to alleviate temperature stress, bacterial infection and arsenic pollution. Whereas diet containing Se-NPs at 0.2 mg kg-1 diet and EPA + DHA at 0.6% was noticeably enhanced the stress in P. hypophthalmus.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34593853 PMCID: PMC8484548 DOI: 10.1038/s41598-021-98582-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Composition and proximate analysis of experimental diet (% dry matter) of selenium nanoparticles (Se-NPs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) fed to Pangasianodon hypophthalmus during the experimental period of 105 days.
| Ingredient | Control diet | Selenium nanoparticles (Se-NPs) + EPA + DHA | ||
|---|---|---|---|---|
| Selenium and EPA + DHA free diet | 0.2 mg/kg + 5 mg/kg diet | 0.2 mg/kg + 10 mg/kg diet | 0.2 mg/kg + 15 mg/kg diet | |
| Soybean meala | 35.5 | 35.5 | 35.5 | 35.5 |
| Fish meala | 20.0 | 20.0 | 20.0 | 20.0 |
| Groundnut meala | 10.0 | 10.0 | 10.0 | 10.0 |
| Wheat floura | 23.47 | 23.4698 | 23.4698 | 23.4698 |
| Cod liver oila | 6.0 | 5.8 | 5.6 | 5.4 |
| CMCb | 2.0 | 2.0 | 2.0 | 2.0 |
| Vitamin and mineral mix* | 2.0 | 2.0 | 2.0 | 2.0 |
| Lecithin | 1.0 | 1.0 | 1.0 | 1.0 |
| Vitamin Cd | 0.03 | 0.03 | 0.03 | 0.03 |
| Selenium Nanoparticles (Se-NPs) | 0 | 0.0002 | 0.0002 | 0.0002 |
| EPA + DHA | 0 | 0.2 | 0.4 | 0.6 |
| CP1 | 36.49 ± 0.69 | 35.54 ± 0.580.46 | 35.64 ± | 34.96 ± 0.11 |
| EE2 | 9.27 ± 0.30 | 11.41 ± 0.55 | 11.45 ± 0.11 | 11.89 ± 0.63 |
| Ash | 8.48 ± 0.15 | 10.19 ± 0.30 | 10.74 ± 0.14 | 10.92 ± 0.47 |
| TC3 | 45.76 ± 0.35 | 42.86 ± 0.90 | 42.17 ± 0.33 | 42.23 ± 0.38 |
| OM4 | 91.52 ± 0.15 | 89.81 ± 0.30 | 89.26 ± 0.14 | 89.08 ± 0.47 |
| DM5 | 92.93 ± 0.61 | 92.36 ± 0.30 | 92.74 ± 0.04 | 91.83 ± 0.13 |
| DE6 | 393.90 ± 0.58 | 393.48 ± 1.98 | 391.40 ± 0.70 | 391.99 ± 3.53 |
CP1—crude protein; EE2—ether extract; TC3—total carbohydrate; OM4—organic matter, DM5—dry matter, DE6—digestible energy.
Digestible energy (DE) (Kcal/100 g) = (% CP × 4) + (% EE × 9) + (TC × 4).
Data expressed as mean ± SE, n = 3.
*Manual prepared selenium free mineral mixture; Composition of vitamin mineral mix (quantity/250 g starch powder): vitamin A 550,000 IU; vitamin D3 110,000 IU; vitamin B1:20 mg; vitamin E 75 mg; vitamin K 100 mg; vitamin B12 0.6 mcg; calcium pantothenate 250 mg; nicotinamide 1000 mg; pyridoxine: 100 mg; Mn 2700 mg; I 100 mg; Zn: 500 mg; Fe 750 mg; Cu 200 mg; Co 45 mg; Ca 50 g; P 30 g.
aProcured from local market, bHimedia Ltd, c*Prepared manually and all components from Himedia Ltd, cSD Fine Chemicals Ltd., India.
Details of the experimental design.
| Treatment number (s) | Treatments | Treatments details | Symbols |
|---|---|---|---|
| 1 | Control group | No exposure to stressors (arsenic + temperature and no supplementation of Se-NPs and EPA + DHA) and fed with control diet | Control |
| 2 | Arsenic (2.68 mg L−1) and high temperature (34 °C) exposure | Concurrent exposure to arsenic (2.68 mg L−1) and high temperature (34 °C) and fed with control diet | As + T |
| 3 | Se-NPs at 0.2 mg kg−1 diet with EPA + DHA at 0.2% | Fed with Se-NPs at 0.2 mg kg−1 and mixture of EPA + DHA at 0.2% | Se-NPs + ED-0.2% |
| 4 | Se-NPs at 0.2 mg kg−1 diet with EPA + DHA at 0.4% | Fed with Se-NPs at 0.2 mg kg−1 and mixture of EPA + DHA at 0.4% | Se-NPs + ED-0.4% |
| 5 | Se-NPs at 0.2 mg kg−1 diet with EPA + DHA at 0.6% | Fed with Se-NPs at 0.2 mg kg−1 and mixture of EPA + DHA at 0.6% | Se-NPs + ED-0.6% |
| 6 | Fed with Se-NPs at 0.2 mg kg−1 diet with EPA + DHA at 0.2% and concurrent exposure to arsenic and high temperature | Fed with Se-NPs at 0.2 mg kg−1 and mixture of EPA + DHA at 0.2% and treated under concurrent exposure to arsenic 2.68 mg L−1) and high temperature (34 °C) | Se-NPs + ED-0.2% |
| 7 | Fed with Se-NPs at 0.2 mg kg−1 diet with EPA + DHA at 0.4% and concurrent exposure to arsenic and high temperature | Fed with Se-NPs at 0.2 mg kg−1 and mixture of EPA + DHA at 0.4% and treated under concurrent exposure to arsenic 2.68 mg L−1) and high temperature (34 °C) | Se-NPs + ED-0.4% |
| 8 | Fed with Se-NPs at 0.2 mg kg−1 diet with EPA + DHA at 0.6% and concurrent exposure to arsenic and high temperature | Fed with Se-NPs at 0.2 mg kg−1 and mixture of EPA + DHA at 0.6% and treated under concurrent exposure to arsenic 2.68 mg L−1) and high temperature (34 °C) | Se-NPs + ED-0.6% |
Figure 1(A) Size of selenium-nanoparticles (203.5 nm) and (B) zeta potential − 41.8 mV.
Figure 2(A, B) Mitigation of primary and secodary stress response (Cortisol and HSP 70) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature (As + T) for 105 days. Within endpoints and groups, bars with different superscripts differ significantly (a–d) cortisol (p = 0.032), HSP-L (p = 0.026), HSP-G (p = 0.014). Data expressed as Mean ± SE (n = 3).
Mitigation of secondary stress response (catalase and superoxide dismutase) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.
| Treatments | Non-stressors | Stressors (arsenic and temperature) | Non-stressors | Stressors (arsenic and temperature) | P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Diets | Control | Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | |
| CAT-Liver | 3.96d ± 0.26 | 6.70f. ± 0.61 | 2.29c ± 0.19 | 0.91a ± 0.13 | 4.24e ± 0.31 | 2.13c ± 0.24 | 1.29b ± 0.11 | 6.39f. ± 0.18 | 0.0023 |
| CAT-Gill | 3.11c ± 0.40 | 8.44d ± 0.61 | 1.61b ± 0.25 | 0.78a ± 0.08 | 3.04c ± 0.53 | 1.52b ± 0.28 | 0.81a ± 0.07 | 3.21c ± 0.59 | 0.014 |
| CAT-Kidney | 5.73c ± 0.76 | 9.01d ± 0.38 | 2.68b ± 0.29 | 1.04a ± 0.15 | 5.09c ± 0.41 | 2.22b ± 0.31 | 1.20a ± 0.19 | 9.47d ± 0.92 | 0.002 |
| SOD-Liver | 66.0b ± 1.82 | 75.04d ± 1.14 | 66.71b ± 1.16 | 62.02a ± 1.13 | 70.85c ± 1.09 | 66.75b ± 1.50 | 62.59a ± 0.58 | 72.07c ± 0.91 | 0.034 |
| SOD-Gill | 31.49a ± 1.23 | 38.71b ± 0.58 | 30.63a ± 1.44 | 32.01a ± 1.40 | 30.31a ± 1.84 | 32.26a ± 0.80 | 30.15a ± 1.96 | 30.84a ± 1.46 | 0.027 |
| SOD-Kidney | 41.16a ± 1.29 | 46.66b ± 2.16 | 42.32a ± 1.54 | 40.57a ± 0.98 | 43.34ab ± 1.25 | 40.97a ± 0.95 | 41.0a ± 1.52 | 47.15b ± 1.46 | 0.043 |
Values in the same row with different superscript (a, b, c, d, e, f) differ significantly. Data expressed as Mean ± SE (n = 6). Catalase and SOD: Units/mg protein.
Mitigation of secondary stress response (glutathione-s-transferase (GST), glutathione peroxidase (GPx) and lipid peroxidation (LPO)) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.
| Treatments | Non-stressors | Stressors (arsenic and temperature) | Non-stressors | Stressors (arsenic and temperature) | P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Diets | Control | Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | |
| GST-Liver | 0.29b ± 0.01 | 0.44d ± 0.02 | 0.19a ± 0.02 | 0.14a ± 0.01 | 0.27b ± 0.03 | 0.18a ± 0.01 | 0.12a ± 0.03 | 0.36c ± 0.01 | 0.011 |
| GST-Gill | 0.35b ± 0.04 | 0.46c ± 0.02 | 0.24ab ± 0.02 | 0.14a ± 0.01 | 0.33b ± 0.06 | 0.23ab ± 0.01 | 0.17a ± 0.01 | 0.43c ± 0.05 | 0.041 |
| GST-Kidney | 0.25c ± 0.01 | 0.45d ± 0.03 | 0.19b ± 0.02 | 0.13a ± 0.01 | 0.23c ± 0.02 | 0.18b ± 0.03 | 0.11a ± 0.01 | 0.41d ± 0.04 | 0.0013 |
| GPx-Liver | 4.90c ± 0.57 | 9.19e ± 0.51 | 2.19b ± 0.25 | 1.52a ± 0.17 | 4.25c ± 0.28 | 2.09b ± 0.40 | 1.55a ± 0.21 | 6.00d ± 0.46 | 0.0035 |
| GPx-Gill | 3.98c ± 0.24 | 8.55e ± 0.31 | 2.94b ± 0.49 | 1.46a ± 0.14 | 3.67c ± 0.35 | 2.97b ± 0.28 | 1.57a ± 0.16 | 7.43d ± 0.75 | 0.041 |
| GPx-Kidney | 8.49c ± 0.47 | 12.25d ± 1.27 | 3.33b ± 0.45 | 1.54a ± 0.26 | 7.90c ± 0.58 | 3.33b ± 0.34 | 1.56a ± 0.25 | 11.12d ± 0.61 | 0.0023 |
| LPO-Liver | 17.94c ± 0.56 | 39.61e ± 1.67 | 12.59b ± 0.49 | 10.66a ± 0.65 | 18.59c ± 0.71 | 18.11c ± 1.12 | 9.77a ± 0.42 | 30.38d ± 1.78 | 0.028 |
| LPO-Gill | 11.38b ± 1.44 | 17.47c ± 0.41 | 8.26a ± 0.65 | 7.08a ± 0.43 | 10.19b ± 0.44 | 7.46a ± 0.32 | 7.90a ± 0.43 | 17.57c ± 0.,57 | 0.023 |
| LPO-Kidney | 23.72c ± 1.05 | 32.95d ± 0.97 | 16.85b ± 0.38 | 10.28a ± 0.70 | 21.39c ± 0.51 | 15.48b ± 1.13 | 10.33a ± 0.70 | 31.07d ± 2.16 | 0.034 |
Values in the same row with different superscript (a, b, c, d, e) differ significantly. Data expressed as Mean ± SE (n = 6). GST and GPx: Units/mg protein. LPO: n mole TBARS formed/h/mg protein.
Figure 3(A, B) Mitigation of secondary stress response (acetylcholine esterase and vitamin C) through dietary selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature (As + T) for 105 days. Within endpoints and groups, bars with different superscripts differ significantly (a–f) AChE-B (p = 0.0028), AChE-M (p = 0.029), VitC-B (p = 0.0056), VitC-M-G (p = 0.038). Data expressed as Mean ± SE (n = 6).
Mitigation of secondary stress response (total protein, albumin, globulin, A:G ratio and blood glucose) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.
| Treatments | Non-stressors | Stressors (arsenic and temperature) | Non-stressors | Stressors (arsenic and temperature) | P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Diets | Control | Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | |
| Total Protein | 0.52b ± 0.02 | 0.40a ± 0.01 | 0.56b ± 0.03 | 0.63c ± 0.06 | 0.35a ± 0.03 | 0.54b ± 0.01 | 0.65c ± 0.03 | 0.35a ± 0.01 | 0.001 |
| Albumin | 0.19b ± 0.01 | 0.18b ± 0.02 | 0.13a ± 0.01 | 0.12a ± 0.02 | 0.11a ± 0.01 | 0.13a ± 0.02 | 0.12a ± 0.02 | 0.10a ± 0.01 | 0.038 |
| Globulin | 0.33b ± 0.03 | 0.22a ± 0.01 | 0.43c ± 0.03 | 0.51d ± 0.06 | 0.24a ± 0.02 | 0.42c ± 0.05 | 0.53d ± 0.03 | 0.24a ± 0.02 | 0.0041 |
| A:G Ratio | 0.60d ± 0.09 | 0.81e ± 0.04 | 0.30ab ± 0.01 | 0.25a ± 0.05 | 0.45c ± 0.11 | 0.34b ± 0.04 | 0.24a ± 0.01 | 0.43c ± 0.03 | 0.0051 |
| NBT | 0.49b ± 0.01 | 0.40a ± 0.02 | 0.55c ± 0.06 | 0.60d ± 0.03 | 0.46b ± 0.02 | 0.56c ± 0.06 | 0.60d ± 0.01 | 0.39a ± 0.02 | 0.002 |
| Blood glucose | 128.81c ± 10.01 | 158.99e ± 2.45 | 121.56b ± 1.75 | 105.46a ± 3.14 | 127.36c ± 5.15 | 121.84b ± 1.50 | 105.14a ± 7.92 | 148.93d ± 8.08 | 0.0063 |
Values in the same row with different superscript (a, b, c, d, e) differ significantly. Total protein, albumin, globulin: g dL−1 Blood glucose: mgdL−1; Data expressed as Mean ± SE (n = 3).
Figure 4(A,B) Mitigation of secondary stress response (total immunoglobulin and myeloperoxiadase) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature (As + T) for 105 days. Within endpoints and groups, bars with different superscripts differ significantly (a–f) Total immunoglobulin (p = 0.0042), Myeloperoxidase (p = 0.017). Data expressed as Mean ± SE (n = 6).
Mitigation of secondary stress response (total lipid, cholesterol, phospholipid, triglyceride and VLDL) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.
| Treatments | Non-stressors | Stressors (arsenic and temperature) | Non-stressors | Stressors (arsenic and temperature) | P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Diets | Control | Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | |
| Total lipid | 13.95c ± 0.91 | 20.42d ± 0.42 | 9.02b ± 0.28 | 6.97a ± 0.52 | 15.08c ± 0.71 | 10.42b ± 0.39 | 8.23ab ± 0.15 | 19.59d ± 0.60 | 0.0067 |
| Cholesterol | 5.34c ± 0.20 | 7.01d ± 0.03 | 3.89b ± 0.18 | 2.59a ± 0.14 | 5.77c ± 0.10 | 4.04b ± 0.12 | 2.84a ± 0.08 | 7.10d ± 0.11 | 0.0073 |
| Phospholipid | 4.72b ± 0.25 | 5.93c ± 0.31 | 3.60a ± 0.05 | 3.49a ± 0.21 | 5.99c ± 0.15 | 4.94b ± 0.29 | 3.78a ± 0.18 | 6.08c ± 0.20 | 0.039 |
| Triglyceride | 3.88c ± 1.26 | 7.49d ± 0.13 | 1.53b ± 0.22 | 0.88a ± 0.52 | 3.31c ± 0.80 | 1.43b ± 0.09 | 1.61b ± 0.12 | 6.41d ± 0.55 | 0.018 |
| VLDL | 0.78c ± 0.25 | 1.50d ± 0.03 | 0.30b ± 0.02 | 0.18a ± 0.04 | 0.66c ± 0.10 | 0.29b ± 0.16 | 0.32b ± 0.02 | 1.28d ± 0.11 | 0.024 |
Values in the same row with different superscript (a, b, c, d) differ significantly. Data expressed as Mean ± SE (n = 3). Total lipid; cholesterol; phospholipid; triglyceride; very low density lipoprotein (VLDL) mg dL−1.
Mitigation of tertairy stress response (final body weight gain, FCR, PER, DGI, TGC and RFI) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.
| Treatments | Non-stressors | Stressors (arsenic and temperature) | Non-stressors | Stressors (arsenic and temperature) | P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Diets | Control | Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | |
| Final body weight gain % | 95.09b ± 5.73 | 73.67a ± 6.62 | 127.01c ± 9.35 | 215.04e ± 11.61 | 102.51bc ± 4.37 | 123.33c ± 13.37 | 199.50d ± 1.15 | 96.80b ± 8.11 | 0.029 |
| FCR | 3.39c ± 0.13 | 4.16d ± 0.28 | 2.88b ± 0.15 | 2.08a ± 0.08 | 3.24c ± 0.13 | 3.02bc ± 0.23 | 2.18a ± 0.04 | 3.46c ± 0.23 | 0.016 |
| SGR | 0.68b ± 0.04 | 0.57a ± 0.02 | 0.87 cd ± 0.03 | 1.16d ± 0.02 | 0.72c ± 0.03 | 0.86 cd ± 0.07 | 1.10d ± 0.03 | 0.68b ± 0.02 | 0.0078 |
| PER | 0.85b ± 0.04 | 0.78a ± 0.05 | 1.08c ± 0.03 | 1.51e ± 0.05 | 0.96b ± 0.06 | 1.06c ± 0.09 | 1.40d ± 0.02 | 0.90b ± 0.05 | 0.031 |
| DGI (%) | 0.92b ± 0.03 | 0.74a ± 0.05 | 1.12c ± 0.05 | 1.61d ± 0.04 | 0.92b ± 0.04 | 1.13c ± 0.09 | 1.59d ± 0.01 | 0.93b ± 0.06 | 0.0043 |
| TGC | 0.0396c ± 0.0008 | 0.0307a ± 0.0005 | 0.0390c ± 0.0003 | 0.0388c ± 0.0002 | 0.0391c ± 0.0005 | 0.0297b ± 0.0001 | 0.0307c ± 0.0001 | 0.0305c ± 0.0002 | 0.012 |
| RFI | 321.12b ± 7.73 | 303.06a ± 7.12 | 363.07c ± 9.30 | 444.58d ± 7.91 | 330.88b ± 3.09 | 366.09c ± 14.99 | 434.19d ± 7.99 | 331.32b ± 7.58 | 0.0038 |
Values in the same row with different superscript (a, b, c, d, e) differ significantly. Data expressed as Mean ± SE (n = 3). FCR: feed conversion ratio; SGR: specific growth rate; PER: protein efficiency ratio; DGI: Daily growth index; TGC: Thermal growth coefficient; RFI: relative feed intake.
Figure 5(A,B) Mitigation of tertiary stress response (relative survival (%) and cumulative mortality) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature (As + T) for 105 days. Data expressed as Mean ± SE (n = 30).
Mitigation of tertiary stress response (residue accumulation of arsenic) through dietary supplementation of selenium nanoparticles, eicosapentanoic acid and dicosahexanoic acid fed to P. hypophthalmus reared in control or under arsenic and high temperature for 105 days.
| Treatments | Non-stressors | Stressors (arsenic and temperature) | Non-stressors | Stressors (arsenic and temperature) | ||||
|---|---|---|---|---|---|---|---|---|
| Diets | Control | Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% |
| Water (µg L−1) | 2.56b ± 0.39 | 868.47f. ± 32.05 | 2.91b ± 0.43 | 1.59a ± 0.17 | 1.12a ± 0.07 | 513.54d ± 57.24 | 326.72c ± 47.32 | 774.05e ± 51.02 |
| Liver (mg kg−1) | 0.09a ± 0.01 | 6.42c ± 0.52 | 0.02a ± 0.01 | 0.04a ± 0.01 | 0.02a ± 0.01 | 0.13b ± 0.01 | 0.07a ± 0.02 | 0.11b ± 0.01 |
| Muscle (mg kg−1) | 0.02a ± 0.0033 | 1.93c ± 0.31 | 0.01a ± 0.001 | 0.02a ± 0.001 | 0.03a ± 0.007 | 0.09b ± 0.005 | 0.08b ± 0.004 | 0.09b ± 0.003 |
| Gill (mg kg−1) | 0.05a ± 0.02 | 1.98c ± 0.41 | 0.04a ± 0.001 | 0.05a ± 0.02 | 0.09a ± 0.01 | 0.17b ± 0.06 | 0.14b ± 0.01 | 0.20b ± 0.02 |
| Kidney (mg kg−1) | 0.19a ± 0.05 | 7.98c ± 0.43 | 0.10a ± 0.001 | 0.10a ± 0.04 | 0.20a ± 0.06 | 0.46b ± 0.001 | 0.10a ± 0.001 | 0.52b ± 0.09 |
| Brain (mg kg−1) | 0.015a ± 0.003 | 1.23c ± 0.002 | 0.013a ± 0.001 | 0.014a ± 0.002 | 0.087c ± 0.004 | 0.059b ± 0.003 | 0.012a ± 0.001 | 0.090c ± 0.002 |
| Muscle-Se (mg kg−1) | 0.72c ± 0.05 | 0.75c ± 0.04 | 0.64b ± 0.12 | 0.92d ± 0.02 | 0.31a ± 0.03 | 0.74c ± 0.05 | 0.56ab ± 0.09 | 0.40a ± 0.03 |
Values in the same row with different superscript (a, b, c, d, e) differ significantly p < 0.05; Data expressed as Mean ± SE (n = 3).
Mineral profiling of experimental diets.
| Elements (mg kg−1) | Experimental diets | |||
|---|---|---|---|---|
| Control | Se-NPs + EPA + DHA-0.2% | Se-NPs + EPA + DHA-0.4% | Se-NPs + EPA + DHA-0.6% | |
| Lithium | 0.47 ± 0.03 | 0.63 ± 0.08 | 0.74 ± 0.04 | 0.93 ± 0.07 |
| Sodium | 452.65 ± 2.85 | 523.63 ± 4.17 | 485.65 ± 6.73 | 642.81 ± 9.79 |
| Magnesium | 368.45 ± 12.56 | 418.47 ± 11.81 | 437.82 ± 5.86 | 518.67 ± 14.85 |
| Potassium | 719.56 ± 11.12 | 813.56 ± 12.51 | 756.89 ± 7.13 | 802.65 ± 11.82 |
| Calcium | 642.56 ± 17.52 | 845.65 ± 15.28 | 784.56 ± 14.75 | 815.81 ± 17.69 |
| Vanadium | 0.047 ± 0.002 | 0.038 ± 0.004 | 0.024 ± 0.001 | 0.031 ± 0.006 |
| Chromium | 1.56 ± 0.08 | 0.89 ± 0.08 | 1.05 ± 0.081 | 0.92 ± 0.12 |
| Manganese | 4.28 ± 0.79 | 3.45 ± 0.29 | 4.63 ± 0.53 | 4.18 ± 0.038 |
| Iron | 114.56 ± 1.67 | 98.65 ± 2.43 | 124.83 ± 4.13 | 132.74 ± 4.21 |
| Cobalt | 0.38 ± 0.07 | 0.21 ± 0.03 | 0.42 ± 0.08 | 0.29 ± 0.036 |
| Nickel | 0.78 ± 0.03 | 0.47 ± 0.04 | 0.69 ± 0.036 | 0.71 ± 0.04 |
| Copper | 2.18 ± 0.07 | 1.85 ± 0.41 | 2.09 ± 0.074 | 2.37 ± 0.058 |
| Zinc | 5.89 ± 0.68 | 6.85 ± 1.28 | 7.18 ± 0.123 | 6.43 ± 0.28 |
| Gallium | 0.26 ± 0.04 | 0.38 ± 0.02 | 0.62 ± 0.045 | 0.41 ± 0.02 |
| Arsenic | 0.18 ± 0.01 | 0.24 ± 0.04 | 0.12 ± 0.06 | 0.16 ± 0.03 |
| Rubidium | 0.75 ± 0.03 | 0.92 ± 0.06 | 0.87 ± 0.017 | 1.01 ± 0.07 |
| Molybdenum | 0.43 ± 0.02 | 0.19 ± 0.042 | 0.37 ± 0.02 | 0.86 ± 0.06 |
Data expressed as Mean ± SE (n = 3). Unit: mg kg−1 of diet.